drugset / Trial / NCT00576563
Rectal Study: Value of Repeated FDG-PET-CT Scans in Rectal Cancer
NaSingle-groupOpen-labelTreatment
Summary
To investigate the evolution of the 18F-deoxyglucose (FDG) uptake and the tumour characteristics determined in the plasma of patients with rectal cancer during and after radiotherapy or combined radiotherapy and chemotherapy. The changes of the FDG uptake of the primary tumour and the evolution of key tumour characteristics during radiotherapy alone or in combination with chemotherapy will be predictive for the pathological tumour response. Study hypothesis The changes of the FDG uptake of the primary tumour and the evolution of key tumour characteristics during radiotherapy alone or in combination with chemotherapy will be predictive for the pathological tumour response.
Timeline
- Start
- 2007-03
- Primary completion
- 2015-01
- Completion
- 2015-12
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | 18F-deoxyglucose | Diagnostic / imaging agent | — | Intravenous |